Management of acute hematogenous osteomyelitis in children

Expert Review of Anti-Infective Therapy

Volumn 8, Issue 2, 2010, Pages 175-181

  Harik, Nada S ^a   Smeltzer, Mark S ^b  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

acute hematogenous osteomyelitis; AHO; antibiotic therapy; CA MRSA; children; community acquired methicillin resistant Staphylococcus aureus; diagnostic imaging; osteomyelitis; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; LINEZOLID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BONE MARROW SUPPRESSION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HEMATOGENOUS OSTEOMYELITIS; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE ATROPHY; PATIENT ASSESSMENT; PERIPHERAL NEUROPATHY; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ACUTE DISEASE; CHILD; MICROBIOLOGY; OSTEOMYELITIS; STAPHYLOCOCCUS INFECTION;

ACUTE DISEASE; ANTI-INFECTIVE AGENTS; CHILD; HUMANS; OSTEOMYELITIS; STAPHYLOCOCCAL INFECTIONS;

EID: 85047687074     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.09.130     Document Type: Review

References (32)

1. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 364(9431), 369-379 (2004).
2. Krogstad P. Osteomyelitis. In: Textbook of Pediatric Infectious Diseases (6th Edition). Feigin RD, Cherry JD, Demmler- Harrison GD, Kaplan SL (Eds). Saunders Elsevier, PA, USA, 725-742 (2009).
3. Li M, An Diep B, Villaruz AE et al. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc. Natl Acad. Sci. USA 106(14), 5883-5888 (2009).
4. Gutierrez K. Bone and joint infections in children. Pediatr. Clin. N. Am. 52(3), 779-794 (2005).
5. Floyed RL, Steele RW. Culture-negative osteomyelitis. Pediatr. Infect. Dis. J. 22(8), 731-736 (2003).
6. Chometon S, Benito Y, Chaker M et al. Specific real-time polymerase chain reaction places Kingella kingae as the most common cause of osteoarticular infections in young children. Pediatr. Infect. Dis. J. 26(5), 377-381 (2007).
7. Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in childrens hospitals in the United States. Clin. Infect. Dis. 49(1), 65-71 (2009).
8. Saavedra-Lozano J, Mejias A, Ahmad N et al. Changing trends in acute osteomyelitis in children: Impact of methicillin-resistant Staphylococcus aureus infections. J. Pediatr. Orthop. 28(5), 569-575 (2008).
9. Martinez-Aguilar GA, Avalos-Mishaan A, Hulten K et al. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr. Infect. Dis. J. 23(8), 701-706 (2004).
10. Bocchini CE, Hulten KG, Mason EO Jr et al. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics 117(2), 433-440 (2006).
11. Sawyer JR, Kapoor M. The limping child: A systemic approach to diagnosis. Am. Fam. Physician 79(3), 215-224 (2009).
12. Unkila-Kallio L, Kallio MJ, Peltola H, Eskola J. Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics 93(1), 59-62 (1994).
13. Pineda C, Vargas A, Rodriguez AV. Imaging of osteomyelitis: Current concepts. Infect. Dis. Clin. N. Am. 20(4), 789-825 (2006).
14. Connolly LP, Connolly SA, Drubach LA, Jaramillo D, Treves ST. Acute hematogenous osteomyelitis of children: Assessment of skeletal scintigraphy-based diagnosis in the era of MRI. J. Nucl. Med. 43(10), 1310-1316 (2002).
15. Browne LP, Mason EO, Kaplan SL, Cassady CI, Krishnamurthy R, Guillerman RP. Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children. Pediatr. Radiol. 38(8), 841-847 (2008).
16. Basu S, Chryssikos T, Moghadem-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emisson tomography as a diagnostic tool in infection: Present role and future possibilities. Semin. Nucl. Med. 39(1), 36-51 (2009).
17. Strobel K, Stumpe KD. PET/CT in musculoskeletal infection. Semin. Musculoskelet. Radiol. 11(4), 353-364 (2007).
18. Chung T. Magnetic resonance imaging in acute osteomyelitis in children. Pediatr. Infect. Dis. J. 21(9), 869-870 (2002).
19. Frank AL, Marcinak JF, Mangat D et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr. Infect. Dis. J. 21(6), 530-534 (2002).
20. Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin. Infect. Dis. 37(9), 1257-1260 (2003).
21. Chen CJ, Chiu CH, Lin TY, Lee ZL, Yang WE, Huang YC. Experience with linezolid therapy in children with osteoarticular infections. Pediatr. Infect. Dis. J. 26(11), 985-988 (2008).
22. Weiss EC, Spencer HJ, Daily SJ, Weiss BD, Smeltzer MS. Impact of sarA on antibiotic susceptibility of Staphylococcus aureus in a catheter-associated in vitro model of biofilm formation. Antimicrob.Agents Chemother. 53(6), 2475-2482 (2009).
23. Weiss ED, Zielinska A, Beenken KE, Spencer HJ, Daily SJ, Smeltzer MS. Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo. Antimicrob. Agents Chemother. 53(10), 4096-4102 (2009).
24. Miro JM, Garcia-de-la-Maria C, Armero Y et al. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53(10), 4172-4177 (2009).
25. Murillo O, Garrigos C, Pachon ME et al. Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53(10), 4252-4257 (2009).
26. Le Saux N, Howard A, Barrowman NJ, Gaboury, Sampson M, Moher D. Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: A systematic review. BMC Infect. Dis. 2, 16-25 (2002).
27. Stryjewski ME, Corey GR. New treatments for methicillin-resistant Staphylococcus aureus. Curr. Opin. Crit. Care 15(5), 403-412 (2009).
28. Thomas MV, Puleo DA. Calcium sulfate: Properties and clinical applications. J. Biomed. Mater. Res. B. Appl. Biomater. 88(2), 597-610 (2009).
29. Zalavras CG, Patzakis MJ, Holtom P. Local antibiotic therapy in the treatment of open fractures and osteomyelitis. Clin. Orthop. Relat. Res. 427, 86-93 (2004).
30. Webb ND, McCanless JD, Courtney HS, Bumgardner JD, Haggard WO. Daptomycin eluted from calcium sulfate appears effective against Staphylococcus. Clin. Orthop. Relat. Res. 466(6), 1383-1387 (2008).
31. Weiss BD, Weiss EC, Haggard WO, Evans RP, McLaren SG, Smeltzer MS. Optimized elution of daptomycin from polymethylmethacrylate beads. Antimicrob. Agents Chemother. 53(1), 264-266 (2008).
32. Kanellakopoulou K, Panagopoulos P, Giannitsioti E et al. In vitro elution of daptomycin by a synthetic crystallic semihydrate form of calcium sulfate, stimulan. Antimicrob. Agents Chemother. 53(7), 3106-3107 (2009).